FRANKFURT (Reuters) - Unlisted German biotech firm CureVac will become the second company after rival BioNTech 22UAy to launch human trials of an experimental coronavirus vaccine in the country, eyeing a potential approval in mid-2021. The trial launch, first reported by Reuters on Tuesday, will see 144 participants in Germany and Belgium receive different dosages…
You don't have permission to access "http://www.medpagetoday.com/publichealthpolicy/medicaid/122032" on this server. Reference #18.8877d917.1783267364.7603bf75 https://errors.edgesuite.net/18.8877d917.1783267364.7603bf75
Here are some highlights and updates related to the great work the FSN team does each week. Published: July 05, 2026, 8:00 am Quick bites from around the food safety arena this week A significant Salmonella outbreak across Europe has sickened more than 100 people now. Children and young adults have been most affected, with 49 victims
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/122026" on this server. Reference #18.9177d917.1783184574.40bb382a https://errors.edgesuite.net/18.9177d917.1783184574.40bb382a